Today, National Investment Services Inc. WI Reduces stake in CVS Health Corporation (CVS)

Today, National Investment Services Inc. WI Reduces stake in CVS Health Corporation (CVS)

National Investment Services Inc. WI decreased its stake in CVS Health Corporation (NYSE:CVS) by 1.3% during the third quarter, Holdings Channel reports. The fund owned 21,811 shares of the pharmacy operator’s stock after selling 297 shares during the period. CVS Health Corporation accounts for about 2.2% of National Investment Services Inc. WI’s holdings, making the stock its 29th largest position. National Investment Services Inc. WI’s holdings in CVS Health Corporation were worth $1,941,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Bank of Montreal Can purchased a new stake in shares of CVS Health Corporation during the second quarter valued at about $438,948,000. Nordea Investment Management AB raised its stake in shares of CVS Health Corporation by 61.3% in the second quarter. Nordea Investment Management AB now owns 11,644,431 shares of the pharmacy operator’s stock valued at $1,114,838,000 after buying an additional 4,423,216 shares during the period. Emerald Acquisition Ltd. purchased a new stake in shares of CVS Health Corporation during the second quarter valued at about $152,524,000. Westwood Holdings Group Inc. raised its stake in shares of CVS Health Corporation by 1,125.2% in the second quarter. Westwood Holdings Group Inc. now owns 1,516,808 shares of the pharmacy operator’s stock valued at $145,220,000 after buying an additional 1,393,009 shares during the period. Finally, Sentry Investments Corp. raised its stake in shares of CVS Health Corporation by 62.1% in the second quarter. Sentry Investments Corp. now owns 3,532,600 shares of the pharmacy operator’s stock valued at $338,211,000 after buying an additional 1,353,000 shares during the period. Institutional investors and hedge funds own 81.78% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 0.53% during mid-day trading on Friday, hitting $74.06. The company had a trading volume of 3,529,190 shares. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $106.67. The company has a 50 day moving average of $81.80 and a 200 day moving average of $91.85. The firm has a market capitalization of $78.98 billion, a PE ratio of 15.87 and a beta of 0.88.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.57 by $0.07. The company earned $44.60 billion during the quarter, compared to analyst estimates of $45.29 billion. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The firm’s revenue was up 15.5% on a year-over-year basis. During the same quarter last year, the business posted $1.28 earnings per share. Analysts predict that CVS Health Corporation will post $5.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, November 3rd. Investors of record on Monday, October 24th were given a $0.425 dividend. The ex-dividend date was Thursday, October 20th. This represents a $1.70 annualized dividend and a yield of 2.30%. CVS Health Corporation’s dividend payout ratio is currently 36.40%.

Several brokerages have issued reports on CVS. Mizuho lifted their price target on CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Citigroup Inc. dropped their price target on CVS Health Corporation from $115.00 to $108.00 and set a “neutral” rating for the company in a research note on Monday, August 8th. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 target price for the company in a research note on Monday, October 24th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Finally, Credit Suisse Group AG reissued a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a research note on Tuesday, September 20th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment